Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged ≥50 years: recommendations of the Advisory Committee on Immunization Practices — United States, 2024

Gong Zhenyu; Gong Xunliang

doi:10.3784/jbjc.202501240046

Gong Zhenyu, Gong Xunliang. Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged ≥50 years: recommendations of the Advisory Committee on Immunization Practices — United States, 2024[J]. Disease Surveillance, 2025, 40(5): 689-692. DOI: 10.3784/jbjc.202501240046

Citation:

Gong Zhenyu, Gong Xunliang. Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged ≥50 years: recommendations of the Advisory Committee on Immunization Practices — United States, 2024[J]. Disease Surveillance, 2025, 40(5): 689-692. DOI: 10.3784/jbjc.202501240046

Citation:

Gong Zhenyu, Gong Xunliang. Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged ≥50 years: recommendations of the Advisory Committee on Immunization Practices — United States, 2024[J]. Disease Surveillance, 2025, 40(5): 689-692. DOI: 10.3784/jbjc.202501240046

Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged ≥50 years: recommendations of the Advisory Committee on Immunization Practices — United States, 2024

Graphical Abstract

Graphical Abstract

Abstract

FullText(HTML)

References (9)

Expanded recommendations for use of pneumococcal conjugate vaccines among adults aged ≥50 years: recommendations of the Advisory Committee on Immunization Practices — United States, 2024

Graphical Abstract

Catalog

Export File

Citation

Format

Content